Chenguang Biotech Group Co.,Ltd.’s Net Profit Rose 24.4% in 2022

Chenguang Biotech Group Co.,Ltd. (晨光生物科技集团股份有限公司) (300138.SZ) reported a net profit of 436.1 million yuan in 2022, up 24.4% year-on-year.

Meanwhile, the company posted 6.3 billion yuan in revenue, up 29.2% year-on-year.

At the end of the reporting period, it had 6.9 billion yuan in total assets and 3.7 billion yuan in total liabilities, with a liability-to-asset ratio of 53.6%.